Antengene to Boost T Cell Engager Platform with AI Investment and DeepSeek Deployment
Company

Antengene to Boost T Cell Engager Platform with AI Investment and DeepSeek Deployment

Jiangxi Rimag Group and Xunfei Healthcare Form Strategic Alliance for Smart Healthcare
CompanyDeals

Jiangxi Rimag Group and Xunfei Healthcare Form Strategic Alliance for Smart Healthcare

Rendu Biological Technology Partners with Green Apple Medical System for RNA Diagnostics Expansion
CompanyDeals

Rendu Biotechnology Partners with Green Apple Medical System for RNA Diagnostics Expansion

Genuine Biotech Files for Hong Kong IPO with Azvudine and ZS-1003 in Pipeline
CompanyDeals

Genuine Biotech Files for Hong Kong IPO with Azvudine and ZS-1003 in Pipeline

AstraZeneca Faces Class Action Lawsuits Over China Legal Issues
CompanyLegal / IP

AstraZeneca Faces Class Action Lawsuits Over China Legal Issues

Biogen Licenses Stoke Therapeutics' Zorevunersen for Dravet Syndrome Outside Americas
CompanyDeals

Biogen Licenses Stoke Therapeutics’ Zorevunersen for Dravet Syndrome Outside Americas

TAHO Pharma's TAH3311 Oral Film Shows Bioequivalence to Eliquis in Study
CompanyDrug

TAHO Pharma’s TAH3311 Oral Film Shows Bioequivalence to Eliquis in Study

Sanofi's Dupixent Receives Priority Review from FDA for Bullous Pemphigoid Treatment
CompanyDrug

Sanofi’s Dupixent Receives Priority Review from FDA for Bullous Pemphigoid Treatment

CSPC Pharma Licenses SYS 6005 to Radiance Biopharma for Global Markets
CompanyDeals

CSPC Pharma Licenses SYS 6005 to Radiance Biopharma for Global Markets

Biokin Pharmaceutical's BL-M07D1 Receives NMPA Approval for Phase II/III Study in HER2+ Breast Cancer
CompanyDrug

Biokin Pharmaceutical’s BL-M07D1 Receives NMPA Approval for Phase II/III Study in HER2+ Breast Cancer

Gilead Sciences' Lenacapavir NDA for HIV Prevention Accepted by FDA for Priority Review
CompanyDrug

Gilead Sciences’ Lenacapavir NDA for HIV Prevention Accepted by FDA for Priority Review

Merck's Welireg Wins Conditional EU Approval for VHL Disease and Advanced RCC
CompanyDrug

Merck’s Welireg Wins Conditional EU Approval for VHL Disease and Advanced RCC